| Micah Alexander Grant, FNP-C | |
|
3549 Bluecutt Rd, Columbus, MS 39705-1324 | |
| (662) 570-4174 | |
| (662) 570-4108 |
| Full Name | Micah Alexander Grant |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 3549 Bluecutt Rd, Columbus, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437558061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WE0003X | Registered Nurse - Emergency | R874310 (Mississippi) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | F0115273 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Weekends Plus Urgent Care Llc | 6608151683 | 7 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
| Entity Name | Oktibbeha County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124144381 PECOS PAC ID: 4587653993 Enrollment ID: O20040511000423 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
| Entity Name | Dutch Medical Clinics, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215276175 PECOS PAC ID: 9234376088 Enrollment ID: O20130515000064 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
| Entity Name | Weekends Plus Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639625411 PECOS PAC ID: 6608151683 Enrollment ID: O20170315000701 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
| Entity Name | Revive Family Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902577554 PECOS PAC ID: 4082002787 Enrollment ID: O20211029001523 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Micah Alexander Grant, FNP-C 3549 Bluecutt Rd, Columbus, MS 39705-1324 Ph: (662) 570-4174 | Micah Alexander Grant, FNP-C 3549 Bluecutt Rd, Columbus, MS 39705-1324 Ph: (662) 570-4174 |
News Archive
The judge ruled on constitutional free speech grounds, but the case could end up in the Supreme Court.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
› Verified 5 days ago
Mrs. Celia Lasky Kidder, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2110 5th St N, Columbus, MS 39705 Phone: 662-243-2435 Fax: 662-328-7037 | |
Dr. Janice Davidson, PHD FNP-BC FAANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 514 7th St S, Columbus, MS 39701 Phone: 662-328-6293 | |
Misti Garnett, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 56 Dutch Ln, Columbus, MS 39702 Phone: 662-329-3808 Fax: 662-329-3873 | |
John S Dornan, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 425 Hospital Dr, Suite 4, Columbus, MS 39705 Phone: 662-240-0650 Fax: 662-240-0483 | |
Christopher Pennington, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 114 N Lehmberg Rd, Columbus, MS 39702 Phone: 662-329-2955 | |
Mrs. Janet Myers, AGACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2042 Fax: 662-244-3287 | |
Lacee Nicole Lowder, MSN, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-1000 |